Management services organization GI Alliance has launched a population health management program, which includes chronic care and principal care management programs. The program launched across GI ...
Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...
Learn more about whether Option Care Health, Inc. or Surgery Partners, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.